We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$227M
AUM Growth
-$6.87M
(-2.9%)
Cap. Flow
-$1.96M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
27.69%
Holding
114
New
9
Increased
33
Reduced
56
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$6.51M |
| 2 |
Blackrock
BLK
|
+$6.46M |
| 3 |
Viatris
VTRS
|
+$4.57M |
| 4 |
Whirlpool
WHR
|
+$3.53M |
| 5 |
Best Buy
BBY
|
+$3.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$8.27M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$5.65M |
| 3 |
Lockheed Martin
LMT
|
+$5.61M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$5.58M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.14% |
| 2 | Technology | 16.57% |
| 3 | Financials | 16.01% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Consumer Staples | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Newmont
NEM
$100B
| $8.21M | 3.61% |
103,328
-555
| -0.5% | -$37.5K |
|
|
2
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66B
| $7.56M | 3.33% |
87,912
+73,303
| +502% | +$6.51M |
|
3
Tyson Foods
TSN
$21B
| $6.66M | 2.93% |
74,329
-595
| -0.8% | -$54.3K |
|
|
4
Blackrock
BLK
$175B
| $6.32M | 2.78% |
+8,267
| New | +$6.46M |
|
5
Microsoft
MSFT
$3.62T
| $6.24M | 2.75% |
20,231
+473
| +2% | +$142K |
|
6
Molson Coors Class B
TAP
$7.86B
| $6.1M | 2.68% |
114,193
+2,640
| +2% | +$133K |
|
7
Huntington Bancshares
HBAN
$35.1B
| $5.73M | 2.52% |
392,124
+707
| +0.2% | +$11.1K |
|
8
Intel
INTC
$459B
| $5.73M | 2.52% |
115,583
+20,511
| +22% | +$1.02M |
|
9
Devon Energy
DVN
$51.4B
| $5.22M | 2.3% |
88,310
-58,842
| -40% | -$3.19M |
|
10
EOG Resources
EOG
$77.6B
| $5.15M | 2.27% |
43,224
-27,142
| -39% | -$3.02M |
|
11
Pfizer
PFE
$143B
| $5M | 2.2% |
96,594
-1,153
| -1% | -$59.8K |
|
12
Invesco
IVZ
$13.6B
| $4.89M | 2.15% |
212,225
+34,765
| +20% | +$771K |
|
|
AVGOP
13
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
| $4.87M | 2.14% |
2,481
-5
| -0.2% | -$9.23K |
|
|
14
Viatris
VTRS
$20.5B
| $4.46M | 1.96% |
410,071
+346,905
| +549% | +$4.57M |
|
15
Citigroup
C
$224B
| $4.45M | 1.96% |
83,291
+4,465
| +6% | +$276K |
|
16
Johnson & Johnson
JNJ
$613B
| $4.43M | 1.95% |
24,988
-372
| -1% | -$63.3K |
|
17
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $3.99M | 1.76% |
109,588
+5,312
| +5% | +$195K |
|
18
CVS Health
CVS
$134B
| $3.87M | 1.7% |
38,271
-706
| -2% | -$74.2K |
|
19
NetApp
NTAP
$35.9B
| $3.86M | 1.7% |
46,540
+607
| +1% | +$52.8K |
|
20
International Paper
IP
$21.9B
| $3.82M | 1.68% |
82,849
+1,467
| +2% | +$67.5K |
|
21
Amgen
AMGN
$204B
| $3.81M | 1.68% |
15,751
-197
| -1% | -$45.3K |
|
22
MetLife
MET
$62B
| $3.62M | 1.59% |
51,507
-920
| -2% | -$62.2K |
|
23
UnitedHealth
UNH
$377B
| $3.56M | 1.57% |
6,990
-184
| -3% | -$88.7K |
|
24
Apple
AAPL
$4.46T
| $3.48M | 1.53% |
19,947
-556
| -3% | -$93.5K |
|
25
Prudential Financial
PRU
$42.7B
| $3.47M | 1.53% |
29,384
-464
| -2% | -$52.8K |
|
Similar funds
MWM
PCC
CF
SGCM
RCWM
LCA
WHCI
FPWM
Palouse Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Palouse Capital Management held 114 positions worth $227M, down 2.9% from $234M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Palouse Capital Management's Q1 2022 filing shows 9 new, 33 increased, 56 reduced and 14 closed positions. Its largest new stake was Blackrock: 8,267 shares worth $6.32M. The largest sale was AbbVie, an estimated $8.27M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
- Palouse Capital Management's largest Q1 2022 buy was Blackrock: 8,267 shares worth $6.32M.
- Palouse Capital Management added most to Vanguard Intermediate-Term Corporate Bond ETF in Q1 2022, an estimated $6.51M increase.
- Palouse Capital Management's biggest Q1 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $5.58M.
- Palouse Capital Management fully exited AbbVie in Q1 2022, selling an estimated $8.27M.
- Palouse Capital Management's ten largest holdings make up 28% of its $227M portfolio in Q1 2022.
- Palouse Capital Management opened 9 new positions and closed 14 in Q1 2022.
- Palouse Capital Management's portfolio value fell 2.9% quarter-over-quarter to $227M.
Based on Palouse Capital Management's 13F filing for Q1 2022, filed 21 Apr 2022.